Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 10:40 PM
NCT ID:
NCT02492867
Group ID:
EG000
Title:
Response-driven Adaptive RT
Description:
Patients received treatment 5 days per week, in once daily fractions, for 30 treatments with dose per fraction individually adapted over the final 9 treatments. Patients may have also received concurrent chemotherapy with Carboplatin and Paclitaxel. Patients may have received consolidation chemotherapy (carboplatin and paclitaxel) or immunotherapy (durvalumab) at the discretion of the medical oncologist.
Response-driven Adaptive Radiation Therapy
Carboplatin: AUC 2 concurrent with RT; AUC 6 during consolidation. Given IV
Paclitaxel: 40 mg/m\^2 IV concurrent with RT; 200 mg/m\^2 during consolidation. Given IV
FDG-PET
V/Q SPECT
Durvalumab: 10 mg/kg during consolidation. Given IV
Deaths Number Affected:
22
Deaths Number At Risk:
None
Serious Number Affected:
13
Serious Number At Risk:
47
Other Number Affected:
47
Other Number At Risk:
47
Study:
NCT02492867
Results Section:
NCT02492867
Adverse Events Module:
NCT02492867